1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. METSERA INC.
Metsera Inc. XNAS: MTSR

Watchlist

Portfolio

Alert


Insider Trading disclosures for Metsera Inc

The latest disclosure was made by Kristina M. Burow in Metsera Inc where a trade of 2,688 Restricted Stock Unit done was reported to US exchanges on Nov. 13, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kristina M. Burow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Nov 2025 2,688 2,688 - - Restricted Stock Unit
Christopher J. Visioli CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Nov 2025 21,250 21,250 - - Restricted Stock Unit
Christopher J. Visioli CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 21,250 0 - - Common Stock
Christopher J. Visioli CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 340,465 0 - - Stock Option (right to buy)
Christopher J. Visioli CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 255,349 0 - - Stock Option (right to buy)
Christopher J. Visioli CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 150,000 0 - - Stock Option (right to buy)
Matthew Lang CHIEF LEGAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 46,875 0 - - Stock Option (right to buy)
Matthew Lang CHIEF LEGAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 325,000 0 - - Stock Option (right to buy)
Matthew Lang CHIEF LEGAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 12,500 0 - - Common Stock
Matthew Lang CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Nov 2025 12,500 12,500 - - Restricted Stock Unit
Joshua Pinto Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 2,688 0 - - Common Stock
Kristina M. Burow Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 16,125 0 - - Stock Option (right to buy)
Kristina M. Burow Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 148,953 0 - - Stock Option (right to buy)
Kristina M. Burow Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 2,688 0 - - Common Stock
Kristina M. Burow Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 17,070,904 0 - - Common Stock
Kristina M. Burow Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 18,503,128 0 - - Common Stock
Kristina M. Burow Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 7,523,682 0 - - Common Stock
Kristina M. Burow Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 8,313,680 0 - - Common Stock
Clive A. Meanwell Director, EXECUTIVE CHAIRMAN Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Nov 2025 5,375 5,375 - - Restricted Stock Unit
Steven Marso CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Nov 2025 17,000 17,000 - - Restricted Stock Unit
Brian Hubbard CHIEF SCIENTIFIC OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 106,395 0 - - Stock Option (right to buy)
Brian Hubbard CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Nov 2025 17,000 17,000 - - Restricted Stock Unit
Brian Hubbard CHIEF SCIENTIFIC OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 17,000 0 - - Common Stock
Brian Hubbard CHIEF SCIENTIFIC OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 120,000 0 - - Stock Option (right to buy)
Brian Hubbard CHIEF SCIENTIFIC OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 319,186 0 - - Stock Option (right to buy)
Steven Marso CHIEF MEDICAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 17,000 0 - - Common Stock
Steven Marso CHIEF MEDICAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 21,279 0 - - Stock Option (right to buy)
Steven Marso CHIEF MEDICAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 829,885 0 - - Stock Option (right to buy)
Steven Marso CHIEF MEDICAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 120,000 0 - - Stock Option (right to buy)
Clive A. Meanwell Director, EXECUTIVE CHAIRMAN Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 12,767,462 0 - - Common Stock
Christopher Whitten Bernard Director, See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 12,767,462 0 - - Common Stock
Christopher Whitten Bernard Director, See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 21,250 0 - - Common Stock
Christopher Whitten Bernard Director, See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 348,750 0 - - Stock Option (right to buy)
Christopher Whitten Bernard Director, See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 1,702,328 0 - - Stock Option (right to buy)
Christopher Whitten Bernard Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Nov 2025 21,250 21,250 - - Restricted Stock Unit
Joshua Pinto Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 148,953 0 - - Stock Option (right to buy)
Joshua Pinto Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 16,125 0 - - Stock Option (right to buy)
Joshua Pinto Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Nov 2025 2,688 2,688 - - Restricted Stock Unit
Clive A. Meanwell Director, EXECUTIVE CHAIRMAN Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 5,375 0 - - Common Stock
Jon P. Stonehouse Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 2,688 0 - - Common Stock
Jon P. Stonehouse Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 47,730 0 - - Stock Option (right to buy)
Jon P. Stonehouse Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Nov 2025 2,688 2,688 - - Restricted Stock Unit
Paul L. Berns Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Nov 2025 4,031 4,031 - - Restricted Stock Unit
Paul L. Berns Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 957,559 0 - - Common Stock
Paul L. Berns Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 8,313,680 0 - - Common Stock
Paul L. Berns Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 7,523,682 0 - - Common Stock
Paul L. Berns Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 4,031 0 - - Common Stock
Paul L. Berns Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 223,430 0 - - Stock Option (right to buy)
Paul L. Berns Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 24,188 0 - - Stock Option (right to buy)
Clive A. Meanwell Director, EXECUTIVE CHAIRMAN Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 32,250 0 - - Stock Option (right to buy)
Clive A. Meanwell Director, EXECUTIVE CHAIRMAN Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Nov 2025 297,907 0 - - Stock Option (right to buy)
Joshua Pinto Director Gift of securities by or to the insider at price $ 0.00 per share. 20 May 2025 148,953 148,953 - - Stock Option (Right to Buy)
Paul L. Berns Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 24,188 24,188 - - Stock Option (Right to Buy)
Clive A. Meanwell Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 32,250 32,250 - - Stock Option (Right to Buy)
Kristina M. Burow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 16,125 16,125 - - Stock Option (Right to Buy)
Matthew Lang Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 46,875 46,875 - - Stock Option (Right to Buy)
Christopher J. Visioli Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 150,000 150,000 - - Stock Option (Right to Buy)
Joshua Pinto Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 16,125 16,125 - - Stock Option (Right to Buy)
Joshua Pinto Director Gift of securities by or to the insider at price $ 0.00 per share. 20 May 2025 148,953 0 - - Stock Option (Right to Buy)
Christopher Whitten Bernard Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 348,750 348,750 - - Stock Option (Right to Buy)
Steven Marso Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 120,000 120,000 - - Stock Option (Right to Buy)
Brian Hubbard Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2025 120,000 120,000 - - Stock Option (Right to Buy)
Jon P. Stonehouse Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2025 47,730 47,730 - - Stock Option (Right to Buy)
Paul L. Berns Director 03 Feb 2025 7,523,682 7,523,682 - - Common Stock
Paul L. Berns Director 03 Feb 2025 2,678,571 0 - - Series B Convertible Preferred Stock
Paul L. Berns Director Purchase of securities on an exchange or from another person at price $ 18.00 per share. 03 Feb 2025 789,998 8,313,680 - 18 14,219,964 Common Stock
Paul L. Berns Director 03 Feb 2025 15,000,000 0 - - Series A Convertible Preferred Stock
Kristina M. Burow Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 18.00 per share. 03 Feb 2025 789,998 8,313,680 - 18 14,219,964 Common Stock
Kristina M. Burow Director, Ten Percent Owner 03 Feb 2025 15,000,000 0 - - Series A Convertible Preferred Stock
Kristina M. Burow Director, Ten Percent Owner 03 Feb 2025 2,678,571 0 - - Series B Convertible Preferred Stock
Kristina M. Burow Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 18.00 per share. 03 Feb 2025 1,432,224 18,503,128 - 18 25,780,032 Common Stock
Kristina M. Burow Director, Ten Percent Owner 03 Feb 2025 7,523,682 7,523,682 - - Common Stock
Kristina M. Burow Director, Ten Percent Owner 03 Feb 2025 2,678,571 0 - - Series B Convertible Preferred Stock
Kristina M. Burow Director, Ten Percent Owner 03 Feb 2025 15,000,000 0 - - Series A Convertible Preferred Stock
Kristina M. Burow Director, Ten Percent Owner 03 Feb 2025 16,006,949 17,070,904 - - Common Stock
Kristina M. Burow Director, Ten Percent Owner 03 Feb 2025 19,933,333 0 - - Series Seed Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters